APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: a pilot study.

Primary Objective: The influence of apolipoprotein (APOE) on neuropsychological outcome was investigated in 19 patients (25.79 ± 7.22 years) with mild-to-moderate traumatic brain injury and 14 matched healthy control subjects (27.